Compare Crocs, Inc. (CROX) vs Marvell Technology Inc (MRVL) Price & Performance

Crocs (CROX) trades at $116.84, down 2.81% today, amid bearish technical signals but strong fundamental valuation metrics. The stock shows attractive P/E of 10.23 and P/S of 1.46, with robust profitability margins including 57.47% gross margin and 42.3% ROE. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $4.55 surpassing the $4.35 estimate. The company maintains strong cash flow generation despite a net loss in 2025, with management focusing on product innovation and HEYDUDE brand repositioning.

CROX presents a compelling value opportunity with discounted valuation multiples relative to historical performance, though near-term technical weakness and competitive pressures warrant caution. Analyst consensus remains bullish with $136.78 price target representing 17% upside potential. Key risks include consumer discretionary spending sensitivity and execution challenges with brand diversification initiatives. The stock's current levels offer entry points for long-term investors seeking exposure to a profitable footwear company with strong brand recognition.

Marvell Technology (MRVL) trades at $274.66, down 4.3% over 24 hours, amid strong bullish technical signals and robust analyst sentiment. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at 1.1. Revenue growth accelerated to 42% in fiscal 2026, driven by data center demand, while profitability metrics like a 52.21% gross margin underscore operational strength. Recent news highlights major custom AI chip deals, including a potential $120 billion agreement with Google.

Outlook remains positive given elevated AI infrastructure spending and raised fiscal 2028 revenue guidance to $18 billion. Risks include high valuation multiples (P/E of 94.26) and dependence on hyperscaler demand. With 84% analyst buy ratings and a $327.86 consensus target, the stock offers growth potential but requires monitoring of competitive and execution risks.